---
title: "Halozyme Therapeutics Elects New Board Member"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/269002666.md"
description: "On December 4, 2025, Halozyme Therapeutics, Inc. announced the election of James Lang to its Board of Directors. Mr. Lang will serve until the annual meeting of stockholders in 2027.IndividualJames LangRoleDirectorType of ChangeAppointedEffective DateDec 4, 2025ReasonNot disclosedReplacement InfoN/ABackground DetailsN/ABoard/Committee Role ChangesNot disclosedOriginal SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - 8-K - Dec. 08, 2025DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC."
datetime: "2025-12-08T22:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269002666.md)
  - [en](https://longbridge.com/en/news/269002666.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269002666.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/269002666.md) | [English](https://longbridge.com/en/news/269002666.md)


# Halozyme Therapeutics Elects New Board Member

On December 4, 2025, Halozyme Therapeutics, Inc. announced the election of James Lang to its Board of Directors. Mr. Lang will serve until the annual meeting of stockholders in 2027.

**Individual**

James Lang

**Role**

Director

**Type of Change**

Appointed

**Effective Date**

Dec 4, 2025

**Reason**

Not disclosed

**Replacement Info**

N/A

**Background Details**

N/A

**Board/Committee Role Changes**

Not disclosed

Original SEC Filing: HALOZYME THERAPEUTICS, INC. \[ HALO \] - 8-K - Dec. 08, 2025

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### 相關股票

- [Halozyme Therap (HALO.US)](https://longbridge.com/zh-HK/quote/HALO.US.md)

## 相關資訊與研究

- [Halozyme Therapeutics Touts $1.8B Revenue Outlook, ENHANZE Royalties and New Hypercon Deals at Conference](https://longbridge.com/zh-HK/news/279535511.md)
- [12 AI stocks that will skyrocket](https://longbridge.com/zh-HK/news/279274043.md)
- [Bank of Marin’s AI Experiments Raise Operational, Compliance, and Regulatory Risk](https://longbridge.com/zh-HK/news/279142436.md)
- [Andersons Director Sells 15,000 Shares](https://longbridge.com/zh-HK/news/279470293.md)
- [James Gillis appointed to ReposiTrak board, joins Audit and Compensation Committees](https://longbridge.com/zh-HK/news/279482163.md)